ARCI Approves 10 Amendments to Model Rules

At its most recent meeting in Tucson, AZ, the Association of Racing Commissioners International (ARCI), approved 10 amendments to the Model Rules.

The Amendments approved are:

· Amendment to ARCI-011-020 MEDICATIONS AND PROHIBITED SUBSTANCES (E) which prohibits the administration of Non-Steroidal Anti-Inflammatory medications to horses within 48 hours of a race

· Amendment to ARCI-011-020 MEDICATIONS AND PROHIBITED SUBSTANCES (F) wherein a horse is ineligible to race in a flat race for 14 days after an intra-articular joint injection

· Amendment to ARCI-010-030 HORSES INELIGIBLE (10) wherein any horse in flat or jump racing will be ineligible to race if it has received an intra-articularinjection in the preceding 14 days and stacking is prohibited

· Amendment to ARCI-011-015 PROHIBITED PRACTICES by adding a new subsection prohibiting the use of bisphosphonates in any horse younger than 4. The bisphosphonatesmust be FDA approved, administered according to instructions, and only used to treat navicular disease

· Amendment to ARCI-011-020 MEDICATIONS AND PROHIBITED SUBSTANCES (B) by dramatically increasing penalties considered to be violations in “doping” and “equine endangerment”

· Amendment to ARCI-010-020 WEIGHTS by altering weight allowances for jockeys riding 3-year-olds facing older horses and for 3-year-old horses facingolder horses

· Amendment to ARCI-011-015 PROHIBITED PRACTICES (6C), by adding subsection (D) outlining under which circumstances other than laboratory testing a horse'sblood can be drawn and by adding subsection (F) prohibiting chemical or immunocastration

· Amendment to ARCI-004-024 (K) PARI-MUTUEL WAGERING by adding language to address wagering opportunities in races with three or more horses.

A proposed amendment to ARCI-010-035 RUNNING OF THE RACE–USE OF THE RIDING CROP (E) was referred to the Rider and Driver Safety Committee to be considered along with alternative proposals being submitted.

 

Not a subscriber? Click here to sign up for the daily PDF or alerts.

Copy Article Link

X

Never miss another story from the TDN

Click Here to sign up for a free subscription.